Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 9 (RPL31P9) is a processed pseudogene of the RPL31 gene, which encodes a structural protein component of the 60S subunit of cytoplasmic ribosomes[1][8][9]. Pseudogenes such as RPL31P9 do not produce functional proteins; instead, they are the result of gene duplication or retrotransposition events that have rendered them non-coding due to the accumulation of disabling mutations[8]. While the functional RPL31 gene is implicated in ribosome assembly and protein synthesis, the pseudogene RPL31P9 has no known protein product or biological function, does not serve enzymatic, receptor, transporter, or signaling roles, and is not a direct disease target or biomarker[8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 9 (RPL31P9).